{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:53:17Z","timestamp":1777863197377,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08064-7","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:49:37Z","timestamp":1777391377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HMGN2 deficiency drives DLBCL progression through impaired R-loop formation and PI3K-AKT hyperactivation"],"prefix":"10.1186","volume":"24","author":[{"given":"Jinman","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiewen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueping","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunman","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changxiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9849-2573","authenticated-orcid":false,"given":"Dan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"9","key":"8064_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","volume":"384","author":"LH Sehn","year":"2021","unstructured":"Sehn LH, Salles G. Diffuse large B-Cell Lymphoma. N Engl J Med. 2021;384(9):842\u201358. https:\/\/doi.org\/10.1056\/NEJMra2027612.","journal-title":"N Engl J Med"},{"issue":"9844","key":"8064_CR2","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","volume":"380","author":"KR Shankland","year":"2012","unstructured":"Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. Lancet. 2012;380(9844):848\u201357. https:\/\/doi.org\/10.1016\/S0140-6736(12)60605-9.","journal-title":"Lancet"},{"issue":"6769","key":"8064_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403(6769):503\u201311. https:\/\/doi.org\/10.1038\/35000501.","journal-title":"Nature"},{"issue":"15","key":"8064_CR4","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, et al. Genetics and pathogenesis of diffuse large B-Cell lymphoma. N Engl J Med. 2018;378(15):1396\u2013407. https:\/\/doi.org\/10.1056\/NEJMoa1801445.","journal-title":"N Engl J Med"},{"issue":"16","key":"8064_CR5","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","volume":"130","author":"M Crump","year":"2017","unstructured":"Crump M, Neelapu SS, Farooq U, Van Den Neste E, Kuruvilla J, Westin J, et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017;130(16):1800\u201308. https:\/\/doi.org\/10.1182\/blood-2017-03-769620.","journal-title":"Blood"},{"issue":"9","key":"8064_CR6","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1182\/bloodadvances.2021004665","volume":"5","author":"EJ Bataillard","year":"2021","unstructured":"Bataillard EJ, Cheah CY, Maurer MJ, Khurana A, Eyre TA, El-Galaly TC. Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review. Blood Adv. 2021;5(9):2426\u201337. https:\/\/doi.org\/10.1182\/bloodadvances.2021004665.","journal-title":"Blood Adv"},{"issue":"1","key":"8064_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13045-021-01134-x","volume":"14","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhou X, Wang X. Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities. J Hematol Oncol. 2021;14(1):125. https:\/\/doi.org\/10.1186\/s13045-021-01134-x.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"8064_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrc3774","volume":"14","author":"DW Scott","year":"2014","unstructured":"Scott DW, Gascoyne RD. The tumour microenvironment in B cell lymphomas. Nat Rev Cancer. 2014;14(8):517\u201334. https:\/\/doi.org\/10.1038\/nrc3774.","journal-title":"Nat Rev Cancer"},{"key":"8064_CR9","doi-asserted-by":"publisher","unstructured":"Hirayama M, Shinriki S, Matsui H. R-loops in normal and malignant hematopoiesis. Front Hematol. 2023;2. https:\/\/doi.org\/10.3389\/frhem.2023.1297657.","DOI":"10.3389\/frhem.2023.1297657"},{"issue":"2","key":"8064_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.molcel.2012.04.009","volume":"46","author":"A Aguilera","year":"2012","unstructured":"Aguilera A, Garc\u00eda-Muse T. R loops: from transcription byproducts to threats to genome stability. Mol Cell. 2012;46(2):115\u201324. https:\/\/doi.org\/10.1016\/j.molcel.2012.04.009.","journal-title":"Mol Cell"},{"issue":"1","key":"8064_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41590-021-01087-w","volume":"23","author":"V Shukla","year":"2022","unstructured":"Shukla V, Samaniego-Castruita D, Dong Z, Gonz\u00e1lez-Avalos E, Yan Q, Sarma K, et al. TET deficiency perturbs mature B cell homeostasis and promotes oncogenesis associated with accumulation of G-quadruplex and R-loop structures. Nat Immunol. 2022;23(1):99\u2013108. https:\/\/doi.org\/10.1038\/s41590-021-01087-w.","journal-title":"Nat Immunol"},{"issue":"1","key":"8064_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13059-018-1593-z","volume":"19","author":"X Ren","year":"2018","unstructured":"Ren X, Kang B, Zhang Z. Understanding tumor ecosystems by single-cell sequencing: promises and limitations. Genome Biol. 2018;19(1):211. https:\/\/doi.org\/10.1186\/s13059-018-1593-z.","journal-title":"Genome Biol"},{"issue":"50","key":"8064_CR13","doi-asserted-by":"publisher","first-page":"6748","DOI":"10.1038\/s41388-021-02054-3","volume":"40","author":"P Bischoff","year":"2021","unstructured":"Bischoff P, Trinks A, Obermayer B, Pett JP, Wiederspahn J, Uhlitz F, et al. Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma. Oncogene. 2021;40(50):6748\u201358. https:\/\/doi.org\/10.1038\/s41388-021-02054-3.","journal-title":"Oncogene"},{"issue":"10","key":"8064_CR14","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.ccell.2021.08.011","volume":"39","author":"CB Steen","year":"2021","unstructured":"Steen CB, Luca BA, Esfahani MS, Azizi A, Sworder BJ, Nabet BY, et al. The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma. Cancer Cell. 2021;39(10):1422\u201337. e1410. https:\/\/doi.org\/10.1016\/j.ccell.2021.08.011.","journal-title":"Cancer Cell"},{"issue":"1","key":"8064_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41421-023-00559-7","volume":"9","author":"N Liu","year":"2023","unstructured":"Liu N, Jiang C, Yao X, Fang M, Qiao X, Zhu L, et al. Single-cell landscape of primary central nervous system diffuse large B-cell lymphoma. Cell Discov. 2023;9(1):55. https:\/\/doi.org\/10.1038\/s41421-023-00559-7.","journal-title":"Cell Discov"},{"issue":"3","key":"8064_CR16","doi-asserted-by":"publisher","first-page":"110713","DOI":"10.1016\/j.celrep.2022.110713","volume":"39","author":"X Ye","year":"2022","unstructured":"Ye X, Wang L, Nie M, Wang Y, Dong S, Ren W, et al. A single-cell atlas of diffuse large B cell lymphoma. Cell Rep. 2022;39(3):110713. https:\/\/doi.org\/10.1016\/j.celrep.2022.110713.","journal-title":"Cell Rep"},{"issue":"6","key":"8064_CR17","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1158\/2159-8290.CD-20-0839","volume":"11","author":"N Kotlov","year":"2021","unstructured":"Kotlov N, Bagaev A, Revuelta MV, Phillip JM, Cacciapuoti MT, Antysheva Z, et al. Clinical and biological subtypes of B-cell lymphoma revealed by microenvironmental signatures. Cancer Discov. 2021;11(6):1468\u201389. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0839.","journal-title":"Cancer Discov"},{"issue":"13","key":"8064_CR18","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1182\/blood.2020006784","volume":"138","author":"W Xu","year":"2021","unstructured":"Xu W, Berning P, Lenz G. Targeting B-cell receptor and PI3K signaling in diffuse large B-cell lymphoma. Blood. 2021;138(13):1110\u201319. https:\/\/doi.org\/10.1182\/blood.2020006784.","journal-title":"Blood"},{"issue":"3","key":"8064_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.molcel.2019.01.024","volume":"73","author":"MP Crossley","year":"2019","unstructured":"Crossley MP, Bocek M, Cimprich KA. R-Loops as cellular regulators and genomic threats. Mol Cell. 2019;73(3):398\u2013411. https:\/\/doi.org\/10.1016\/j.molcel.2019.01.024.","journal-title":"Mol Cell"},{"issue":"7","key":"8064_CR20","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41556-020-0532-x","volume":"22","author":"T Roider","year":"2020","unstructured":"Roider T, Seufert J, Uvarovskii A, Frauhammer F, Bordas M, Abedpour N, et al. Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels. Nat Cell Biol. 2020;22(7):896\u2013906. https:\/\/doi.org\/10.1038\/s41556-020-0532-x.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"8064_CR21","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nat Biotechnol. 2015;33(5):495\u2013502. https:\/\/doi.org\/10.1038\/nbt.3192.","journal-title":"Nat Biotechnol"},{"issue":"12","key":"8064_CR22","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16(12):1289\u201396. https:\/\/doi.org\/10.1038\/s41592-019-0619-0.","journal-title":"Nat Methods"},{"issue":"5","key":"8064_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics: J Intgr Biol. 2012;16(5):284\u201387. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"Omics: J Intgr Biol"},{"key":"8064_CR24","doi-asserted-by":"publisher","unstructured":"Cui X, Qin F, Yu X, Xiao F, Cai G. SCISSOR\u2122: a single-cell inferred site-specific omics resource for tumor microenvironment association study. NAR Cancer. 2021;3(3):zcab037. https:\/\/doi.org\/10.1093\/narcan\/zcab037.","DOI":"10.1093\/narcan\/zcab037"},{"key":"8064_CR25","doi-asserted-by":"publisher","unstructured":"Lin R, Zhong X, Zhou Y, Geng H, Hu Q, Huang Z, et al. R-loopBase: a knowledgebase for genome-wide R-loop formation and regulation. Nucleic Acids Res. 2022;50(D1):D303\u2013D315. https:\/\/doi.org\/10.1093\/nar\/gkab1103.","DOI":"10.1093\/nar\/gkab1103"},{"issue":"10","key":"8064_CR26","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, et al. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017;14(10):979\u201382. https:\/\/doi.org\/10.1038\/nmeth.4402.","journal-title":"Nat Methods"},{"key":"8064_CR27","doi-asserted-by":"publisher","unstructured":"Yang JM, Zhang N, Luo T, Yang M, Shen WK, Tan ZL, et al. TCellSI: a novel method for T cell state assessment and its applications in immune environment prediction. Imeta. 2024;3(5):e231. https:\/\/doi.org\/10.1002\/imt2.231.","DOI":"10.1002\/imt2.231"},{"issue":"1","key":"8064_CR28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","volume":"20","author":"S Jin","year":"2025","unstructured":"Jin S, Plikus MV, Nie Q. CellChat for systematic analysis of cell\u2013cell communication from single-cell transcriptomics. Nat Protoc. 2025;20(1):180\u2013219. https:\/\/doi.org\/10.1038\/s41596-024-01045-4.","journal-title":"Nat Protoc"},{"issue":"2","key":"8064_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj G, Manning BD. The PI3K\u2013AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 2020;20(2):74\u201388. https:\/\/doi.org\/10.1038\/s41568-019-0216-7.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"8064_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","volume":"30","author":"J\u00c1F Fresno Vara","year":"2004","unstructured":"Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonz\u00e1lez-Bar\u00f3n M. PI3K\/Akt signalling pathway and cancer. Cancer Treat Rev. 2004;30(2):193\u2013204. https:\/\/doi.org\/10.1016\/j.ctrv.2003.07.007.","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"8064_CR31","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018;24(5):679\u201390. https:\/\/doi.org\/10.1038\/s41591-018-0016-8.","journal-title":"Nat Med"},{"issue":"4","key":"8064_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","volume":"37","author":"GW Wright","year":"2020","unstructured":"Wright GW, Huang DW, Phelan JD, Coulibaly ZA, Roulland S, Young RM, et al. A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell. 2020;37(4):551\u201368. e514. https:\/\/doi.org\/10.1016\/j.ccell.2020.03.015.","journal-title":"Cancer Cell"},{"issue":"1","key":"8064_CR33","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1146\/annurev-immunol-020711-075027","volume":"30","author":"AL Shaffer 3rd","year":"2012","unstructured":"Shaffer AL 3rd, Young RM, Staudt LM. Pathogenesis of human B cell lymphomas. Annu Rev Immunol. 2012;30(1):565\u2013610. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-075027.","journal-title":"Annu. Rev. Immunol"},{"issue":"8","key":"8064_CR34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nri3865","volume":"15","author":"M Swiecki","year":"2015","unstructured":"Swiecki M, Colonna M. The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol. 2015;15(8):471\u201385. https:\/\/doi.org\/10.1038\/nri3865.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"8064_CR35","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15(8):486\u201399. https:\/\/doi.org\/10.1038\/nri3862.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"8064_CR36","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.immuni.2016.04.019","volume":"44","author":"LK Ward-Kavanagh","year":"2016","unstructured":"Ward-Kavanagh LK, Lin WW, \u0160ed\u00fd JR, Ware CF. The TNF receptor superfamily in co-stimulating and co-inhibitory responses. Immunity. 2016;44(5):1005\u201319. https:\/\/doi.org\/10.1016\/j.immuni.2016.04.019.","journal-title":"Immunity"},{"issue":"20","key":"8064_CR37","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.4161\/15384101.2014.949111","volume":"13","author":"V Oakes","year":"2014","unstructured":"Oakes V, Wang W, Harrington B, Lee WJ, Beamish H, Chia KM, et al. Cyclin A\/Cdk2 regulates Cdh1 and claspin during late S\/G2 phase of the cell cycle. Cell Cycle. 2014;13(20):3302\u201311. https:\/\/doi.org\/10.4161\/15384101.2014.949111.","journal-title":"Cell Cycle"},{"issue":"35","key":"8064_CR38","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1200\/JCO.2017.75.4648","volume":"35","author":"M Dreyling","year":"2017","unstructured":"Dreyling M, Santoro A, Mollica L, Lepp\u00e4 S, Follows GA, Lenz G, et al. Phosphatidylinositol 3-kinase inhibition by Copanlisib in relapsed or refractory indolent lymphoma. JCO. 2017;35(35):3898\u2013905. https:\/\/doi.org\/10.1200\/JCO.2017.75.4648.","journal-title":"JCO"},{"issue":"6","key":"8064_CR39","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.ccr.2013.05.002","volume":"23","author":"L Chen","year":"2013","unstructured":"Chen L, Monti S, Juszczynski P, Ouyang J, Chapuy B, Neuberg D, et al. SYK inhibition modulates distinct PI3K\/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas. Cancer Cell. 2013;23(6):826\u201338. https:\/\/doi.org\/10.1016\/j.ccr.2013.05.002.","journal-title":"Cancer Cell"},{"issue":"3","key":"8064_CR40","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1365-2141.2009.07851.x","volume":"147","author":"KA Sarosiek","year":"2009","unstructured":"Sarosiek KA, Nechushtan H, Lu X, Rosenblatt JD, Lossos IS. Interleukin-4 distinctively modifies responses of germinal centre-like and activated B-cell-like diffuse large B-cell lymphomas to immuno-chemotherapy. Br J Haematol. 2009;147(3):308\u201318. https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07851.x.","journal-title":"Br J Haematol"},{"issue":"1","key":"8064_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neo.2021.12.001","volume":"24","author":"S Chang","year":"2022","unstructured":"Chang S, Li B, Xie Y, Wang Y, Xu Z, Jin S, et al. DCZ0014, a novel compound in the therapy of diffuse large B-cell lymphoma via the B cell receptor signaling pathway. Neoplasia. 2022;24(1):50\u201361. https:\/\/doi.org\/10.1016\/j.neo.2021.12.001.","journal-title":"Neoplasia"},{"issue":"1","key":"8064_CR42","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/1476-4598-13-178","volume":"13","author":"L Su","year":"2014","unstructured":"Su L, Hu A, Luo Y, Zhou W, Zhang P, Feng Y. HMGN2, a new anti-tumor effector molecule of CD8+ T cells. Mol Cancer. 2014;13(1):178. https:\/\/doi.org\/10.1186\/1476-4598-13-178.","journal-title":"Mol Cancer"},{"issue":"3","key":"8064_CR43","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.3892\/or.2014.3689","volume":"33","author":"G Liang","year":"2015","unstructured":"Liang G, Xu E, Yang C, Zhang C, Sheng X, Zhou X. Nucleosome-binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2-OS osteosarcoma cell lines. Oncol Rep. 2015;33(3):1300\u201306. https:\/\/doi.org\/10.3892\/or.2014.3689.","journal-title":"Oncol Rep"},{"key":"8064_CR44","doi-asserted-by":"publisher","first-page":"1056917","DOI":"10.3389\/fonc.2022.1056917","volume":"12","author":"Z Wu","year":"2022","unstructured":"Wu Z, Huang Y, Yuan W, Wu X, Shi H, Lu M, et al. Expression, tumor immune infiltration, and prognostic impact of HMGs in gastric cancer. Front Oncol. 2022;12:1056917. https:\/\/doi.org\/10.3389\/fonc.2022.1056917.","journal-title":"Front Oncol"},{"issue":"1","key":"8064_CR45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41375-022-01749-0","volume":"37","author":"W Xu","year":"2023","unstructured":"Xu W, Berning P, Erdmann T, Grau M, Bettazov\u00e1 N, Zapukhlyak M, et al. mTOR inhibition amplifies the anti-lymphoma effect of PI3K\u03b2\/\u03b4 blockage in diffuse large B-cell lymphoma. Leukemia. 2023;37(1):178\u201389. https:\/\/doi.org\/10.1038\/s41375-022-01749-0.","journal-title":"Leukemia"},{"issue":"14","key":"8064_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/cancers17142314","volume":"17","author":"J Weiss","year":"2025","unstructured":"Weiss J, Carty SA, Karimi YH. Molecular pathways and targeted therapies in Relapsed\/Refractory diffuse large B-Cell lymphoma (DLBCL). Cancers (Basel). 2025;17(14):17. https:\/\/doi.org\/10.3390\/cancers17142314.","journal-title":"Cancers (Basel)"},{"issue":"31","key":"8064_CR47","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1200\/JCO.2014.59.0018","volume":"34","author":"PM LoRusso","year":"2016","unstructured":"LoRusso PM. Inhibition of the PI3K\/AKT\/mTOR pathway in solid tumors. JCO. 2016;34(31):3803\u201315. https:\/\/doi.org\/10.1200\/JCO.2014.59.0018.","journal-title":"JCO"},{"issue":"1","key":"8064_CR48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","volume":"18","author":"J Yang","year":"2019","unstructured":"Yang J, Nie J, Ma X, Wei Y, Peng Y, Wei X. Targeting PI3K in cancer: mechanisms and advances in clinical trials. Mol Cancer. 2019;18(1):26. https:\/\/doi.org\/10.1186\/s12943-019-0954-x.","journal-title":"Mol Cancer"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08064-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08064-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08064-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:22:12Z","timestamp":1777526532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08064-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8064"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08064-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"613"}}